Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Testing the NKT cell hypothesis of human IDDM pathogenesis
Peter T. Lee, … , Peter A. Gottlieb, Albert Bendelac
Peter T. Lee, … , Peter A. Gottlieb, Albert Bendelac
Published September 15, 2002
Citation Information: J Clin Invest. 2002;110(6):793-800. https://doi.org/10.1172/JCI15832.
View: Text | PDF
Article Immunology Article has an altmetric score of 7

Testing the NKT cell hypothesis of human IDDM pathogenesis

  • Text
  • PDF
Abstract

Research Article

Authors

Peter T. Lee, Amy Putnam, Kamel Benlagha, Luc Teyton, Peter A. Gottlieb, Albert Bendelac

×

Total citations by year

Year: 2024 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 1 1 2 1 1 3 2 3 10 3 9 7 11 3 9 4 7 1 4 6 2 1 91
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (3)

Title and authors Publication Year
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
L Veinotte, S Gebremeskel, B Johnston
OncoImmunology 2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
M Favreau, K Vanderkerken, D Elewaut, K Venken, E Menu
Oncotarget 2016
A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains
K Kitaura, T Shini, T Matsutani, R Suzuki
BMC Immunology 2016

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 18 patents
Highlighted by 1 platforms
16 readers on Mendeley
See more details